Cation dyshomeostasis and cardiomyocyte necrosis: The Fleckenstein hypothesis revisited

European Heart Journal

Volumn 32, Issue 15, 2011, Pages 1846-1853

  Borkowski, Brian J ^a   Cheema, Yaser ^a   Shahbaz, Atta U ^a   Bhattacharya, Syamal K ^a   Weber, Karl T ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

Acute stressor states; Calcium; Congestive heart failure; Magnesium; Neurohormonal activation; Potassium; Selenium; Zinc

Indexed keywords

ADRENALIN; ANGIOTENSIN II; ANTIBIOTIC AGENT; ANTIDEPRESSANT AGENT; CALCIUM; CATECHOLAMINE; ENDOTHELIN 1; MAGNESIUM; MITOCHONDRIAL PERMEABILITY TRANSITION PORE; NEUROLEPTIC AGENT; PARATHYROID HORMONE; POTASSIUM; REACTIVE OXYGEN METABOLITE; SALBUTAMOL; SPIRONOLACTONE; THIAZIDE DIURETIC AGENT;

ACUTE HEART INFARCTION; CALCIUM CELL LEVEL; CALCIUM EXCRETION; CONGESTIVE HEART FAILURE; CRITICALLY ILL PATIENT; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY MONITORING; HEART ARRHYTHMIA; HEART MUSCLE NECROSIS; HORMONAL REGULATION; HOSPITALIZATION; HUMAN; HYPERTENSION; HYPOALBUMINEMIA; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; MEMBRANE PERMEABILITY; OSTEOLYSIS; OXIDATIVE STRESS; PATHOGENESIS; POTASSIUM BALANCE; POTASSIUM DEPLETION; PRIORITY JOURNAL; QT PROLONGATION; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; REVIEW; SECONDARY HYPERPARATHYROIDISM; SELENIUM DEFICIENCY; SIGNAL TRANSDUCTION; ZINC DEFICIENCY;

APOPTOSIS; CALCIUM; CATIONS; HEART FAILURE; HOMEOSTASIS; HUMANS; HYPERCALCIURIA; HYPOKALEMIA; MITOCHONDRIAL DISEASES; MYOCYTES, CARDIAC; NECROSIS; NEPHROCALCINOSIS; NEUROTRANSMITTER AGENTS; RENAL TUBULAR TRANSPORT, INBORN ERRORS; SELENIUM; SIGNAL TRANSDUCTION; STRESS, PHYSIOLOGICAL; ZINC;

EID: 79961027163     PISSN: 0195668X     EISSN: 15229645     Source Type: Journal    
DOI: 10.1093/eurheartj/ehr063     Document Type: Review

References (159)

1. Matzinger P. The danger model: a renewed sense of self. Science 2002;296: 301-305. (Pubitemid 34303674)
2. Gallucci S, Matzinger P. Danger signals: SOS to the immune system. Curr Opin Immunol 2001;13:114-119. (Pubitemid 32096970)
3. Todryk SM, Melcher AA, Dalgleish AG, Vile RG. Heat shock proteins refine the danger theory. Immunology 2000;99:334-337. (Pubitemid 30137696)
4. Beltrami CA, Finato N, Rocco M, Feruglio GA, Puricelli C, Cigola E, Quaini F, Sonnenblick EH, Olivetti G, Anversa P. Structural basis of end-stage failure in ischemic cardiomyopathy in humans. Circulation 1994;89:151-163. (Pubitemid 24026485)
5. Ishii J, Nomura M, Nakamura Y, Naruse H, Mori Y, Ishikawa T, Ando T, Kurokawa H, Kondo T, Nagamura Y, Ezaki K, Hishida H. Risk stratification using a combination of cardiac troponin T and brain natriuretic peptide in patients hospitalized for worsening chronic heart failure. Am J Cardiol 2002;89: 691-695. (Pubitemid 34230565)
6. Kuwabara Y, Sato Y, Miyamoto T, Taniguchi R, Matsuoka T, Isoda K, Yamane K, Nishi K, Fujiwara H, Takatsu Y. Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes. Circ J 2007;71:1047-1051. (Pubitemid 46998018)
7. Peacock WF IV, De Marco T, Fonarow GC, Diercks D, Wynne J, Apple FS, Wu AH. Cardiac troponin and outcome in acute heart failure. N Engl J Med 2008;358:2117-2126. (Pubitemid 351679598)
8. Zairis MN, Tsiaousis GZ, Georgilas AT, Makrygiannis SS, Adamopoulou EN, Handanis SM, Batika PC, Prekates AA, Velissaris D, Kouris NT, Mytas DZ, Babalis DK, Karidis KS, Foussas SG. Multimarker strategy for the prediction of 31 days cardiac death in patients with acutely decompensated chronic heart failure. Int J Cardiol 2009;141:284-290.
9. Löwbeer C, Gustafsson SA, Seeberger A, Bouvier F, Hulting J. Serum cardiac troponin T in patients hospitalized with heart failure is associated with left ventricular hypertrophy and systolic dysfunction. Scand J Clin Lab Invest 2004;64: 667-676. (Pubitemid 39425306)
10. Horwich TB, Patel J, MacLellan WR, Fonarow GC. Cardiac troponin I is associated with impaired hemodynamics, progressive left ventricular dysfunction, and increased mortality rates in advanced heart failure. Circulation 2003;108: 833-838. (Pubitemid 37022125)
11. Sukova J, Ostadal P, Widimsky P. Profile of patients with acute heart failure and elevated troponin I levels. Exp Clin Cardiol 2007;12:153-156. (Pubitemid 47520918)
12. Ilva T, Lassus J, Siirilä-Waris K, Melin J, Peuhkurinen K, Pulkki K, Nieminen MS, Mustonen H, Porela P, Harjola VP. Clinical significance of cardiac troponins I and T in acute heart failure. Eur J Heart Fail 2008;10:772-779.
13. Sato Y, Nishi K, Taniguchi R, Miyamoto T, Fukuhara R, Yamane K, Saijyo S, Tanada Y, Yamamoto E, Goto T, Takahashi N, Fujiwara H, Takatsu Y. In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events. J Cardiol 2009;54:221-230.
14. Miller WL, Hartman KA, Burritt MF, Grill DE, Jaffe AS. Profiles of serial changes in cardiac troponin T concentrations and outcome in ambulatory patients with chronic heart failure. J Am Coll Cardiol 2009;54:1715-1721.
15. Sundström J, Ingelsson E, Berglund L, Zethelius B, Lind L, Venge P, Arnlöv J. Cardiac troponin-I and risk of heart failure: a community-based cohort study. Eur Heart J 2009;30:773-781.
16. Tan LB, Burniston JG, Clark WA, Ng Y, Goldspink DF. Characterization of adrenoceptor involvement in skeletal and cardiac myotoxicity induced by sympathomimetic agents: toward a new bioassay for beta-blockers. J Cardiovasc Pharmacol 2003;41:518-525. (Pubitemid 36373788)
17. Goldspink DF, Burniston JG, Ellison GM, Clark WA, Tan LB. Catecholamine-induced apoptosis and necrosis in cardiac and skeletal myocytes of the rat in vivo: the same or separate death pathways? Exp Physiol 2004;89: 407-416. (Pubitemid 39023182)
18. Benjamin IJ, Jalil JE, Tan LB, Cho K,Weber KT, ClarkWA. Isoproterenol-induced myocardial fibrosis in relation to myocyte necrosis. Circ Res 1989;65:657-670. (Pubitemid 19226442)
19. Fleckenstein A, Kanke J, Dö ring HJ, Leder O. Key role of Ca in the production of noncoronarogenic myocardial necroses. Recent Adv Stud Cardiac Struct Metab 1975;6:21-32.
20. Lossnitzer K, Janke J, Hein B, Stauch M, Fleckenstein A. Disturbed myocardial calcium metabolism: a possible pathogenetic factor in the hereditary cardiomyopathy of the Syrian hamster. Recent Adv Stud Cardiac Struct Metab 1975;6: 207-217.
21. Bier CB, Rona G. Mineralocorticoid potentiation of isoproterenol-induced myocardial injury: Ultrastructural equivalent. J Mol Cell Cardiol 1979;11:961-966. (Pubitemid 10165479)
22. Rona G, Boutet M, Huttner I. Reperfusion injury. A possible link between catecholamine-induced and ischemic myocardial alterations. Adv Myocardiol 1983;4:427-439.
23. Yates JC, Taam GM, Singal PK, Beamish RE, Dhalla NS. Modification of adrenochrome-induced cardiac contractile failure and cell damage by changes in cation concentrations. Lab Invest 1980;43:316-326. (Pubitemid 10008957)
24. Singal PK, Forbes MS, Sperelakis N. Occurrence of intramitochondrial Ca2+ granules in a hypertrophied heart exposed to adriamycin. Can J Physiol Pharmacol 1984;62:1239-1244. (Pubitemid 14023275)
25. Bybee KA, Prasad A. Stress-related cardiomyopathy syndromes. Circulation 2008; 118:397-409.
26. Brown MJ, Brown DC, Murphy MB. Hypokalemia from beta2-receptor stimulation by circulating epinephrine. N Engl J Med 1983;309:1414-1419. (Pubitemid 14245137)
27. Reid JL, Whyte KF, Struthers AD. Epinephrine-induced hypokalemia: the role of beta adrenoceptors. Am J Cardiol 1986;57:23F-27F. (Pubitemid 16054093)
28. Hansen O, Johansson BW, Nilsson-Ehle P. Metabolic, electrocardiographic, and hemodynamic responses to increased circulating adrenaline: effects of selective and nonselective beta adrenoceptor blockade. Angiology 1990;41:175-188. (Pubitemid 20095394)
29. Tarditi DJ, Hollenberg SM. Cardiac arrhythmias in the intensive care unit. Semin Respir Crit Care Med 2006;27:221-229. (Pubitemid 44061625)
30. Struthers AD, Whitesmith R, Reid JL. Prior thiazide diuretic treatment increases adrenaline-induced hypokalaemia. Lancet 1983;1:1358-1361. (Pubitemid 13100199)
31. Lipworth BJ, McDevitt DG, Struthers AD. Hypokalemic and ECG sequelae of combined beta-agonist/diuretic therapy. Protection by conventional doses of spironolactone but not triamterene. Chest 1990;98:811-815. (Pubitemid 20355482)
32. Burniston JG, Clark WA, Tan LB, Goldspink DF. Dose-dependent separation of the hypertrophic and myotoxic effects of the beta(2)-adrenergic receptor agonist clenbuterol in rat striated muscles. Muscle Nerve 2006;33:655-663.
33. Gupta A, Lawrence AT, Krishnan K, Kavinsky CJ, Trohman RG. Current concepts in the mechanisms and management of drug-induced QT prolongation and torsade de pointes. Am Heart J 2007;153:891-899. (Pubitemid 46809861)
34. Buckley MS, Leblanc JM, Cawley MJ. Electrolyte disturbances associated with commonly prescribed medications in the intensive care unit. Crit Care Med 2010;38:S253-S264.
35. Curtis LH, Østbye T, Sendersky V, Hutchison S, Allen LaPointe NM, Al-Khatib SM, Usdin Yasuda S, Dans PE, Wright A, Califf RM, Woosley RL, Schulman KA. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients. Am J Med 2003;114:135-141. (Pubitemid 36183596)
36. Darrow DC, Miller HC. The production of cardiac lesions by repeated injections of desoxycorticosterone acetate. J Clin Invest 1942;21:601-611.
37. Weglicki WB, Mak IT, Stafford RE, Dickens BF, Cassidy MM, Phillips TM. Neurogenic peptides and the cardiomyopathy of magnesium-deficiency: effects of substance P-receptor inhibition. Mol Cell Biochem 1994;130:103-109. (Pubitemid 24127581)
38. Kramer JH, Spurney C, Iantorno M, Tziros C, Mak IT, Tejero-Taldo MI, Chmielinska JJ, Komarov A, Weglicki WB. Neurogenic inflammation and cardiac dysfunction due to hypomagnesemia. Am J Med Sci 2009;338:22-27.
39. Rayssiguier Y. Hypomagnesemia resulting from adrenaline infusion in ewes: its relation to lipolysis. Horm Metab Res 1977;9:309-314. (Pubitemid 8161456)
40. Escuela MP, Guerra M, Añon JM, Mart́nez-Vizcaino V, Zapatero MD, Garcia-Jalón A, Celaya S. Total and ionized serum magnesium in critically ill patients. Intensive Care Med 2005;31:151-156. (Pubitemid 40174296)
41. Ryzen E. Magnesium homeostasis in critically ill patients. Magnesium 1989;8: 201-212. (Pubitemid 19253961)
42. Ueshima K, Tachibana H, Suzuki T, Hiramori K. Factors affecting the blood concentration of ionized magnesium in patients in the acute phase of myocardial infarction. Heart Vessels 2004;19:267-270. (Pubitemid 39600417)
43. Ceremuzynski L, Van Hao N. Ventricular arrhythmias late after myocardial infarction are related to hypomagnesemia and magnesium loss: preliminary trial of corrective therapy. Clin Cardiol 1993;16:493-496. (Pubitemid 23164236)
44. Saleem AF, Haque A. On admission hypomagnesemia in critically ill children: Risk factors and outcome. Indian J Pediatr 2009;76:1227-1230.
45. Safavi M, Honarmand A. Admission hypomagnesemia-impact on mortality or morbidity in critically ill patients. Middle East J Anesthesiol 2007;19:645-660.
46. Sheehan JP, Seelig MS. Interactions of magnesium and potassium in the pathogenesis of cardiovascular disease. Magnesium 1984;3:301-314.
47. Leier CV, Dei Cas L, Metra M. Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: hyponatremia, hypokalemia, and hypomagnesemia. Am Heart J 1994;128:564-574. (Pubitemid 24298312)
48. Milionis HJ, Alexandrides GE, Liberopoulos EN, Bairaktari ET, Goudevenos J, Elisaf MS. Hypomagnesemia and concurrent acid-base and electrolyte abnormalities in patients with congestive heart failure. Eur J Heart Fail 2002;4:167-173. (Pubitemid 34233503)
49. Kraft MD, Btaiche IF, Sacks GS, Kudsk KA. Treatment of electrolyte disorders in adult patients in the intensive care unit. Am J Health Syst Pharm 2005;62: 1663-1682. (Pubitemid 41153661)
50. Schwinger RH, Erdmann E. Heart failure and electrolyte disturbances. Methods Find Exp Clin Pharmacol 1992;14:315-325.
51. Adeboye AA, Borkowski BJ, Weber KT. Atrial and ventricular arrhythmias in a woman with prolonged QTc, hypokalemia, hypomagnesemia and a metabolic alkalosis [abstr]. J Investig Med 2010;58:365.
52. Carlstedt F, Lind L, Joachimsson PO, Rastad J, Wide L, Ljunghall S. Circulating ionized calcium and parathyroid hormone levels following coronary artery by-pass surgery. Scand J Clin Lab Invest 1999;59:47-53.
53. Carlstedt F, Lind L, Rastad J, Stjernstrom H, Wide L, Ljunghall S. Parathyroid hormone and ionized calcium levels are related to the severity of illness and survival in critically ill patients. Eur J Clin Invest 1998;28:898-903. (Pubitemid 28521580)
54. Carlstedt F, Lind L, Wide L, Lindahl B, Hänni A, Rastad J, Ljunghall S. Serum levels of parathyroid hormone are related to the mortality and severity of illness in patients in the emergency department. Eur J Clin Invest 1997;27:977-981. (Pubitemid 28012617)
55. Hästbacka J, Pettilä V. Prevalence and predictive value of ionized hypocalcemia among critically ill patients. Acta Anaesthesiol Scand 2003;47:1264-1269. (Pubitemid 37452603)
56. Choi YC, Hwang SY. The value of initial ionized calcium as a predictor of mortality and triage tool in adult trauma patients. J Korean Med Sci 2008;23:700-705.
57. Cherry RA, Bradburn E, Carney DE, Shaffer ML, Gabbay RA, Cooney RN. Do early ionized calcium levels really matter in trauma patients? J Trauma 2006; 61:774-779. (Pubitemid 44569402)
58. Dickerson RN, Henry NY, Miller PL, Minard G, Brown RO. Low serum total calcium concentration as a marker of low serum ionized calcium concentration in critically ill patients receiving specialized nutrition support. Nutr Clin Pract 2007;22:323-328.
59. Burchard KW, Simms HH, Robinson A, DiAmico R, Gann DS. Hypocalcemia during sepsis. Relationship to resuscitation and hemodynamics. Arch Surg 1992; 127:265-272.
60. Joborn H, Hjemdahl P, Larsson PT, Lithell H, Lundin L, Wide L, Ljunghall S. Platelet and plasma catecholamines in relation to plasma minerals and parathyroid hormone following acute myocardial infarction. Chest 1990;97:1098-1105. (Pubitemid 20166797)
61. Karlsberg RP, Cryer PE, Roberts R. Serial plasma catecholamine response early in the course of clinical acute myocardial infarction: relationship to infarct extent and mortality. Am Heart J 1981;102:24-29. (Pubitemid 11086984)
62. Gunnewiek JM, Van Der Hoeven JG. Cardiac troponin elevations among critically ill patients. Curr Opin Crit Care 2004;10:342-346. (Pubitemid 39313502)
63. Jeremias A, Gibson CM. Narrative review: alternative causes for elevated cardiac troponin levels when acute coronary syndromes are excluded. Ann Intern Med 2005;142:786-791. (Pubitemid 40593781)
64. Maeder M, Fehr T, Rickli H, Ammann P. Sepsis-associated myocardial dysfunction: diagnostic and prognostic impact of cardiac troponins and natriuretic peptides. Chest 2006;129:1349-1366.
65. Vasile VC, Babuin L, Rio Perez JA, Alegria JR, Song LM, Chai HS, Afessa B, Jaffe AS. Long-term prognostic significance of elevated cardiac troponin levels in critically ill patients with acute gastrointestinal bleeding. Crit Care Med 2009; 37:140-147.
66. Tan IK, Chua KS, Toh AK. Serum magnesium, copper, and zinc concentrations in acute myocardial infarction. J Clin Lab Anal 1992;6:324-328.
67. Versieck J, Barbier F, Speecke A, Hoste J. Influence of myocardial infarction on serum manganese, copper, and zinc concentrations. Clin Chem 1975;21: 578-581.
68. Jain VK, Mohan G. Serum zinc and copper in myocardial infarction with particular reference to prognosis. Biol Trace Elem Res 1991;31:317-322.
69. Arnaud J, Faure H, Bourlard P, Denis B, Favier AE. Longitudinal changes in serum zinc concentration and distribution after acute myocardial infarction. Clin Chim Acta 1994;230:147-156. (Pubitemid 24319740)
70. Lekakis J, Kalofoutis A. Zinc concentrations in serum as related to myocardial infarction. Clin Chem 1980;26:1660-1661. (Pubitemid 11238579)
71. Berger MM, Cavadini C, Chiolero R, Dirren H. Copper, selenium, and zinc status and balances after major trauma. J Trauma 1996;40:103-109. (Pubitemid 26045027)
72. Berger MM, Shenkin A. Update on clinical micronutrient supplementation studies in the critically ill. Curr Opin Clin Nutr Metab Care 2006;9:711-716. (Pubitemid 44624618)
73. Berger MM, Shenkin A, Revelly JP, Roberts E, Cayeux MC, Baines M, Chioléro RL. Copper, selenium, zinc, and thiamine balances during continuous venovenous hemodiafiltration in critically ill patients. Am J Clin Nutr 2004;80: 410-416. (Pubitemid 41080015)
74. Lindeman RD, Bottomley RG, Cornelison RL Jr, Jacobs LA. Influence of acute tissue injury on zinc metabolism in man. J Lab Clin Med 1972;79:452-460.
75. Low WI, Ikram H. Plasma zinc in acute myocardial infarction. Diagnostic and prognostic implications. Br Heart J 1976;38:1339-1342. (Pubitemid 8015298)
76. Selmanpakoglu AN, Cetin C, Sayal A, Işimer A. Trace element (Al, Se, Zn, Cu) levels in serum, urine and tissues of burn patients. Burns 1994;20:99-103. (Pubitemid 24110609)
77. Agay D, Anderson RA, Sandre C, Bryden NA, Alonso A, Roussel AM, Chancerelle Y. Alterations of antioxidant trace elements (Zn, Se, Cu) and related metallo-enzymes in plasma and tissues following burn injury in rats. Burns 2005;31:366-371. (Pubitemid 40363949)
78. Berger MM. Antioxidant micronutrients in major trauma and burns: evidence and practice. Nutr Clin Pract 2006;21:438-449. (Pubitemid 44497057)
79. Berger MM, Baines M, RaffoulW, Benathan M, Chiolero RL, Reeves C, Revelly JP, Cayeux MC, Senechaud I, Shenkin A. Trace element supplementation after major burns modulates antioxidant status and clinical course by way of increased tissue trace element concentrations. Am J Clin Nutr 2007;85:1293-1300. (Pubitemid 46740471)
80. Arroyo M, LaGuardia SP, Bhattacharya SK, Nelson MD, Johnson PL, Carbone LD, Newman KP, Weber KT. Micronutrients in African-Americans with decompensated and compensated heart failure. Transl Res 2006;148: 301-308. (Pubitemid 44880038)
81. Tubek S. Zinc content in lymphocytes and the activity of zinc ion efflux from lymphocytes in primary arterial hypertension. Biol Trace Elem Res 2005;107: 89-99. (Pubitemid 41417099)
82. Oster O, Drexler M, Schenk J, Meinertz T, Kasper W, Schuster CJ, Prellwitz W. The serum selenium concentration of patients with acute myocardial infarction. Ann Clin Res 1986;18:36-42. (Pubitemid 16134553)
83. Bor MV, Cev́k C, Uslu I, Güneral F, Düzgün E. Selenium levels and glutathione peroxidase activities in patients with acute myocardial infarction. Acta Cardiol 1999;54:271-276. (Pubitemid 29504935)
84. Anker SD, Chua TP, Ponikowski P, Harrington D, Swan JW, Kox WJ, Poole-Wilson PA, Coats AJS. Hormonal changes and catabolic/anabolic imbalance in chronic heart failure and their importance for cardiac cachexia. Circulation 1997;96:526-534. (Pubitemid 27329429)
85. Dutka DP, Olivotto I, Ward S, Nihoyannopoulos P, al-Subaili M, Oakley CM, Impallomeni M, Cleland JG. Plasma neuro-endocrine activity in very elderly subjects and patients with and without heart failure. Eur Heart J 1995;16: 1223-1230.
86. Bolger AP, Sharma R, Li W, Leenarts M, Kalra PR, Kemp M, Coats AJ, Anker SD, Gatzoulis MA. Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation 2002;106:92-99. (Pubitemid 34747447)
87. Emdin M, Passino C, Prontera C, Iervasi A, Ripoli A, Masini S, Zucchelli GC, Clerico A. Cardiac natriuretic hormones, neuro-hormones, thyroid hormones and cytokines in normal subjects and patients with heart failure. Clin Chem Lab Med 2004;42:627-636. (Pubitemid 38979140)
88. Buchhorn R, Hammersen A, Bartmus D, Bürsch J. The pathogenesis of heart failure in infants with congenital heart disease. Cardiol Young 2001;11:498-504. (Pubitemid 33735182)
89. Law PH, Sun Y, Bhattacharya SK, Chhokar VS, Weber KT. Diuretics and bone loss in rats with aldosteronism. J Am Coll Cardiol 2005;46:142-146. (Pubitemid 40905142)
90. Soliman HM, Mercan D, Lobo SS, Melot C, Vincent JL. Development of ionized hypomagnesemia is associated with higher mortality rates. Crit Care Med 2003; 31:1082-1087. (Pubitemid 36444417)
91. Ahmed A, Zannad F, Love TE, Tallaj J, Gheorghiade M, Ekundayo OJ, Pitt B. A propensity-matched study of the association of low serum potassium levels and mortality in chronic heart failure. Eur Heart J 2007;28:1334-1343. (Pubitemid 47355979)
92. Adamopoulos C, Pitt B, Sui X, Love TE, Zannad F, Ahmed A. Low serum magnesium and cardiovascular mortality in chronic heart failure: a propensitymatched study. Int J Cardiol 2009;136:270-277.
93. Bowling CB, Pitt B, Ahmed MI, Aban IB, Sanders PW, Mujib M, Campbell RC, Love TE, Aronow WS, Allman RM, Bakris GL, Ahmed A. Hypokalemia and outcomes in patients with chronic heart failure and chronic kidney disease: findings from propensity-matched studies. Circ Heart Fail 2010;3:253-260.
94. Domanski M, Tian X, Haigney M, Pitt B. Diuretic use, progressive heart failure, and death in patients in the DIG study. J Card Fail 2006;12:327-332. (Pubitemid 43817590)
95. Ahmed A, Husain A, Love TE, Gambassi G, Dell'Italia LJ, Francis GS, Gheorghiade M, Allman RM, Meleth S, Bourge RC. Heart failure, chronic diuretic use, and increase in mortality and hospitalization: an observational study using propensity score methods. Eur Heart J 2006;27:1431-1439. (Pubitemid 43998077)
96. Weber KT. Furosemide in the long-term management of heart failure. The good, the bad and the uncertain. J Am Coll Cardiol 2004;44:1308-1310. (Pubitemid 39208890)
97. Cooper HA, Dries DL, Davis CE, Shen YL, Domanski MJ. Diuretics and risk of arrhythmic death in patients with left ventricular dysfunction. Circulation 1999; 100:1311-1315. (Pubitemid 29440124)
98. Domanski M, Norman J, Pitt B, Haigney M, Hanlon S, Peyster E. Diuretic use, progressive heart failure, and death in patients in the Studies Of Left Ventricular Dysfunction (SOLVD). J Am Coll Cardiol 2003;42:705-708. (Pubitemid 37000189)
99. Pitt B, Zannad F, Remme WJ, Cody R, Castaigne A, Perez A, Palensky J, Wittes W. The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators. N Engl J Med 1999;341:709-717. (Pubitemid 29407370)
100. Shane E, Mancini D, Aaronson K, Silverberg SJ, Seibel MJ, Addesso V, McMahon DJ. Bone mass, vitamin D deficiency, and hyperparathyroidism in congestive heart failure. Am J Med 1997;103:197-207. (Pubitemid 27413402)
101. Khouzam RN, Dishmon DA, Farah V, Flax SD, Carbone LD,Weber KT. Secondary hyperparathyroidism in patients with untreated and treated congestive heart failure. Am J Med Sci 2006;331:30-34. (Pubitemid 43177513)
102. LaGuardia SP, Dockery BK, Bhattacharya SK, Nelson MD, Carbone LD, Weber KT. Secondary hyperparathyroidism and hypovitaminosis D in African-Americans with decompensated heart failure. Am J Med Sci 2006;332: 112-118. (Pubitemid 44401230)
103. Alsafwah S, LaGuardia SP, Nelson MD, Battin DL, Newman KP, Carbone LD, Weber KT. Hypovitaminosis D in African Americans residing in Memphis, Tennessee with and without heart failure. Am J Med Sci 2008;335:292-297. (Pubitemid 351548648)
104. Ulrich S, Hersberger M, Fischler M, Huber LC, Senn O, Treder U, Speich R, Schmid C. Bone mineral density and secondary hyperparathyroidism in pulmonary hypertension. Open Respir Med J 2009;3:53-60.
105. Franco CB, Paz-Filho G, Gomes PE, Nascimento VB, Kulak CA, Boguszewski CL, Borba VZ. Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int 2009;20:1881-1887.
106. Fertig A, Webley M, Lynn JA. Primary hyperparathyroidism in a patient with Conn's syndrome. Postgrad Med J 1980;56:45-47. (Pubitemid 10214686)
107. Hellman DE, Kartchner M, Komar N, Mayes D, Pitt M. Hyperaldosteronism, hyperparathyroidism, medullary sponge kidneys, and hypertension. JAMA 1980; 244:1351-1353. (Pubitemid 10003883)
108. Resnick LM, Laragh JH. Calcium metabolism and parathyroid function in primary aldosteronism. Am J Med 1985;78:385-390. (Pubitemid 15107917)
109. Rossi E, Sani C, Perazzoli F, Casoli MC, Negro A, Dotti C. Alterations of calcium metabolism and of parathyroid function in primary aldosteronism, and their reversal by spironolactone or by surgical removal of aldosterone-producing adenomas. Am J Hypertens 1995;8:884-893.
110. Brunaud L, Germain A, Zarnegar R, Rancier M, Alrasheedi S, Caillard C, Ayav A, Weryha G, Mirallie E, Bresler L. Serum aldosterone is correlated positively to parathyroid hormone (PTH) levels in patients with primary hyperparathyroidism. Surgery 2009;146:1035-1041.
111. Andersson P, Rydberg E, Willenheimer R. Primary hyperparathyroidism and heart disease-a review. Eur Heart J 2004;25:1776-1787. (Pubitemid 39330228)
112. Chhokar VS, Sun Y, Bhattacharya SK, Ahokas RA, Myers LK, Xing Z, Smith RA, Gerling IC, Weber KT. Hyperparathyroidism and the calcium paradox of aldosteronism. Circulation 2005;111:871-878. (Pubitemid 40279888)
113. Vidal A, Sun Y, Bhattacharya SK, Ahokas RA, Gerling IC, Weber KT. Calcium paradox of aldosteronism and the role of the parathyroid glands. Am J Physiol Heart Circ Physiol 2006;290:H286-H294.
114. Selektor Y, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT. Cinacalcet and the prevention of secondary hyperparathyroidism in rats with aldosteronism. Am J Med Sci 2008;335:105-110. (Pubitemid 351253405)
115. Gandhi MS, Deshmukh PA, Kamalov G, Zhao T, Zhao W, Whaley JT, Tichy JR, Bhattacharya SK, Ahokas RA, Sun Y, Gerling IC, Weber KT. Causes and consequences of zinc dyshomeostasis in rats with chronic aldosteronism. J Cardiovasc Pharmacol 2008;52:245-252.
116. Kamalov G, Deshmukh PA, Baburyan NY, Gandhi MS, Johnson PL, Ahokas RA, Bhattacharya SK, Sun Y, Gerling IC, Weber KT. Coupled calcium and zinc dyshomeostasis and oxidative stress in cardiac myocytes and mitochondria of rats with chronic aldosteronism. J Cardiovasc Pharmacol 2009;53:414-423.
117. Lee AH, Mull RL, Keenan GF, Callegari PE, Dalinka MK, Eisen HJ, Mancini DM, DiSesa VJ, Attie MF. Osteoporosis and bone morbidity in cardiac transplant recipients. Am J Med 1994;96:35-41. (Pubitemid 24043650)
118. Schmid C, KiowskiW. Hyperparathyroidism in congestive heart failure. Am J Med 1998;104:508-509.
119. Ogino K, Ogura K, Kinugasa Y, Furuse Y, Uchida K, Shimoyama M, Kinugawa T, Osaki S, Kato M, Tomikura Y, Igawa O, Hisatome I, Bilezikian JP, Shigemasa C. Parathyroid hormone-related protein is produced in the myocardium and increased in patients with congestive heart failure. J Clin Endocrinol Metab 2002;87:4722-4727. (Pubitemid 35247067)
120. Zittermann A, Schleithoff SS, Tenderich G, Berthold HK, Korfer R, Stehle P. Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure? J Am Coll Cardiol 2003;41:105-112. (Pubitemid 36044411)
121. Sugimoto T, Tanigawa T, Onishi K, Fujimoto N, Matsuda A, Nakamori S, Matsuoka K, Nakamura T, Koji T, Ito M. Serum intact parathyroid hormone levels predict hospitalisation for heart failure. Heart 2009;95:395-398.
122. Pilz S, Tomaschitz A, Drechsler C, Ritz E, Boehm BO, Grammer TB, März W. Parathyroid hormone level is associated with mortality and cardiovascular events in patients undergoing coronary angiography. Eur Heart J 2010;31: 1591-1598.
123. Hagström E, Hellman P, Larsson TE, Ingelsson E, Berglund L, Sundström J, Melhus H, Held C, Lind L, Michaëlsson K, Arnlöv J. Plasma parathyroid hormone and the risk of cardiovascular mortality in the community. Circulation 2009;119:2765-2771.
124. Hagström E, Ingelsson E, Sundström J, Hellman P, Larsson TE, Berglund L, Melhus H, Held C, Michaëlsson K, Lind L, Ä rnlöv J. Plasma parathyroid hormone and risk of congestive heart failure in the community. Eur J Heart Fail 2010;12:1186-1192.
125. Bell NH, Greene A, Epstein S, Oexmann MJ, Shaw S, Shary J. Evidence for alteration of the vitamin D-endocrine system in blacks. J Clin Invest 1985;76:470-473. (Pubitemid 15227507)
126. Sawaya BP, Monier-Faugere MC, Ratanapanichkich P, Butros R, Wedlund PJ, Fanti P. Racial differences in parathyroid hormone levels in patients with secondary hyperparathyroidism. Clin Nephrol 2002;57:51-55. (Pubitemid 34071626)
127. Zittermann A, Fischer J, Schleithoff SS, Tenderich G, Fuchs U, Koerfer R. Patients with congestive heart failure and healthy controls differ in vitamin D-associated lifestyle factors. Int J Vitam Nutr Res 2007;77:280-288. (Pubitemid 350114349)
128. Zittermann A, Schleithoff SS, Gotting C, Dronow O, Fuchs U, Kuhn J, Kleesiek K, Tenderich G, Koerfer R. Poor outcome in end-stage heart failure patients with low circulating calcitriol levels. Eur J Heart Fail 2008;10:321-327.
129. Zittermann A, Schleithoff SS, Koerfer R. Vitamin D and vascular calcification. Curr Opin Lipidol 2007;18:41-46. (Pubitemid 46090236)
130. Jarvis JK, Miller GD. Overcoming the barrier of lactose intolerance to reduce health disparities. J Natl Med Assoc 2002;94:55-66.
131. Cohen AJ, Roe FJ. Review of risk factors for osteoporosis with particular reference to a possible aetiological role of dietary salt. Food Chem Toxicol 2000;38: 237-253. (Pubitemid 30136274)
132. Teucher B, Dainty JR, Spinks CA, Majsak-Newman G, Berry DJ, Hoogewerff JA, Foxall RJ, Jakobsen J, Cashman KD, Flynn A, Fairweather-Tait SJ. Sodium and bone health: impact of moderately high and low salt intakes on calcium metabolism in postmenopausal women. J Bone Miner Res 2008;23:1477-1485.
133. Kerschan-Schindl K, Strametz-Juranek J, Heinze G, Grampp S, Bieglmayer C, Pacher R, Maurer G, Fialka-Moser V, Pietschmann P. Pathogenesis of bone loss in heart transplant candidates and recipients. J Heart Lung Transplant 2003; 22:843-850. (Pubitemid 36945480)
134. Nishio K, Mukae S, Aoki S, Itoh S, Konno N, Ozawa K, Satoh R, Katagiri T. Congestive heart failure is associated with the rate of bone loss. J Intern Med 2003; 253:439-446. (Pubitemid 36418929)
135. Kenny AM, Boxer R, Walsh S, Hager WD, Raisz LG. Femoral bone mineral density in patients with heart failure. Osteoporos Int 2006;17:1420-1427. (Pubitemid 44127330)
136. Frost RJ, Sonne C,Wehr U, Stempfle HU. Effects of calcium supplementation on bone loss and fractures in congestive heart failure. Eur J Endocrinol 2007;156: 309-314. (Pubitemid 46554498)
137. Abou-Raya S, Abou-Raya A. Osteoporosis and congestive heart failure (CHF) in the elderly patient: double disease burden. Arch Gerontol Geriatr 2009;49: 250-254.
138. van Diepen S, Majumdar SR, Bakal JA, McAlister FA, Ezekowitz JA. Heart failure is a risk factor for orthopedic fracture: a population-based analysis of 16,294 patients. Circulation 2008;118:1946-1952.
139. Carbone LD, Cross JD, Raza SH, Bush AJ, Sepanski RJ, Dhawan S, Khan BQ, Gupta M, Ahmad K, Khouzam RN, Dishmon DA, Nesheiwat JP, Hajjar MA, Chishti WA, Nasser W, Khan M, Womack CR, Cho T, Haskin AR, Weber KT. Fracture risk in men with congestive heart failure. Risk reduction with spironolactone. J Am Coll Cardiol 2008;52:135-138. (Pubitemid 351885442)
140. Garcia Zozaya JL, Padilla Viloria M. [Alterations of calcium, magnesium, and zinc in essential hypertension: their relation to the renin-angiotensin- aldosterone system] [Spanish]. Invest Clin 1997;38 (Suppl. 2):27-40.
141. Golik A, Modai D, Averbukh Z, Sheffy M, Shamis A, Cohen N, Shaked U, Dolev E. Zinc metabolism in patients treated with captopril versus enalapril. Metabolism 1990;39:665-667. (Pubitemid 20198256)
142. Golik A, Zaidenstein R, Dishi V, Blatt A, Cohen N, Cotter G, Berman S, Weissgarten J. Effects of captopril and enalapril on zinc metabolism in hypertensive patients. J Am Coll Nutr 1998;17:75-78. (Pubitemid 28081145)
143. Chmielnicka J, Zareba G, Witasik M, Brzeźnicka E. Zinc-selenium interaction in the rat. Biol Trace Elem Res 1988;15:267-276.
144. Kamalov G, Ahokas RA, Zhao W, Johnson PL, Shahbaz AU, Bhattacharya SK, Sun Y, Gerling IC, Weber KT. Temporal responses to intrinsically coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria during aldosteronism. Am J Physiol Heart Circ Physiol 2010;298:H385-H394.
145. Kamalov G, Ahokas RA, Zhao W, Zhao T, Shahbaz AU, Johnson PL, Bhattacharya SK, Sun Y, Gerling IC, Weber KT. Uncoupling the coupled calcium and zinc dyshomeostasis in cardiac myocytes and mitochondria seen in aldosteronism. J Cardiovasc Pharmacol 2010;55:248-254.
146. Wang J, Song Y, Elsherif L, Song Z, Zhou G, Prabhu SD, Saari JT, Cai L. Cardiac metallothionein induction plays the major role in the prevention of diabetic cardiomyopathy by zinc supplementation. Circulation 2006;113:544-554.
147. Prabhu KS, Zamamiri-Davis F, Stewart JB, Thompson JT, Sordillo LM, Reddy CC. Selenium deficiency increases the expression of inducible nitric oxide synthase in RAW 264.7 macrophages: role of nuclear factor-kB in up-regulation. Biochem J 2002;366 (Pt 1):203-209. (Pubitemid 34971819)
148. Hatanaka N, Nakaden H, Yamamoto Y, Matsuo S, Fujikawa T, Matsusue S. Selenium kinetics and changes in glutathione peroxidase activities in patients receiving long-term parenteral nutrition and effects of supplementation with selenite. Nutrition 2000;16:22-26. (Pubitemid 30050720)
149. Weiss SL, Evenson JK, Thompson KM, Sunde RA. The selenium requirement for glutathione peroxidase mRNA level is half of the selenium requirement for glutathione peroxidase activity in female rats. J Nutr 1996;126:2260-2267. (Pubitemid 26313604)
150. Xia YM, Hill KE, Burk RF. Biochemical studies of a selenium-deficient population in China: measurement of selenium, glutathione peroxidase and other oxidant defense indices in blood. J Nutr 1989;119:1318-1326. (Pubitemid 19268010)
151. van Rij AM, Thomson CD, McKenzie JM, Robinson MF. Selenium deficiency in total parenteral nutrition. Am J Clin Nutr 1979;32:2076-2085. (Pubitemid 10244805)
152. Reeves WC, Marcuard SP, Willis SE, Movahed A. Reversible cardiomyopathy due to selenium deficiency. JPEN J Parenter Enteral Nutr 1989;13:663-665. (Pubitemid 20005572)
153. Boldery R, Fielding G, Rafter T, Pascoe AL, Scalia GM. Nutritional deficiency of selenium secondary to weight loss (bariatric) surgery associated with lifethreatening cardiomyopathy. Heart Lung Circ 2007;16:123-126. (Pubitemid 46436715)
154. Song Y, Wang J, Li XK, Cai L. Zinc and the diabetic heart. Biometals 2005;18: 325-332. (Pubitemid 41298016)
155. Demling RH, DeBiasse MA. Micronutrients in critical illness. Crit Care Clin 1995; 11:651-673.
156. Sriram K, Lonchyna VA. Micronutrient supplementation in adult nutrition therapy: practical considerations. JPEN J Parenter Enteral Nutr 2009;33:548-562.
157. Witte KK, Clark AL, Cleland JG. Chronic heart failure and micronutrients. J Am Coll Cardiol 2001;37:1765-1774. (Pubitemid 32499957)
158. Soukoulis V, Dihu JB, Sole M, Anker SD, Cleland J, Fonarow GC, Metra M, Pasini E, Strzelczyk T, Taegtmeyer H, Gheorghiade M. Micronutrient deficiencies an unmet need in heart failure. J Am Coll Cardiol 2009;54:1660-1673.
159. Bhattacharya SK, Ahokas RA, Carbone LD, Newman KP, Gerling IC, Sun Y, Weber KT. Macro-and micronutrients in African-Americans with heart failure. Heart Fail Rev 2006;11:45-55. (Pubitemid 43986207)